Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 062373

Expand all

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 1.2MG BASE/ML
Marketing Status: Prescription

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1.2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A062373
Product Number: 007
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 1.6MG BASE/ML
Marketing Status: Prescription

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1.6MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A062373
Product Number: 008
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 2MG BASE/ML
Marketing Status: Prescription

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2MG BASE/ML
Reference Listed Drug: No
Reference Standard: Yes
TE Code: 
Application Number: A062373
Product Number: 009
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 80MG BASE/100ML
Marketing Status: Prescription

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 80MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A062373
Product Number: 002
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 100MG BASE/100ML
Marketing Status: Prescription

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 100MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A062373
Product Number: 005
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 120MG BASE/100ML
Marketing Status: Prescription

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 120MG BASE/100ML
Reference Listed Drug: No
Reference Standard: Yes
TE Code: 
Application Number: A062373
Product Number: 006
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 0.8MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 0.8MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062373
Product Number: 001
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 2.4MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2.4MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062373
Product Number: 010
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 40MG BASE/100ML
Marketing Status: Discontinued

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062373
Product Number: 003
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (GENTAMICIN SULFATE)
EQ 60MG BASE/100ML
Marketing Status: Discontinued

Active Ingredient: GENTAMICIN SULFATE
Proprietary Name: GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 60MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062373
Product Number: 004
Approval Date: Sep 7, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information